SL
IONS icon

Salomon & Ludwin’s Ionis Pharmaceuticals IONS Stock Holding History

Salomon & Ludwin’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.8K Hold
332
– – ﹤0.01% 931
2025
Q4 		$26.1K Hold
332
– – ﹤0.01% 702
2025
Q3 		$23K Buy
+332
New +$16.2K ﹤0.01% 732

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Salomon & Ludwin's IONS Position: Q1 2026 in Review

Salomon & Ludwin held its Ionis Pharmaceuticals (IONS) position steady in Q1 2026 at 332 shares worth $24.8K. The position accounts for ﹤0.01% of the portfolio, ranked #931.

Salomon & Ludwin first reported a position in IONS in Q3 2025 and has held it in 3 quarters since. The position peaked at $26.1K in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Salomon & Ludwin held 332 shares of Ionis Pharmaceuticals worth $24.8K as of Q1 2026.
  • Salomon & Ludwin left its Ionis Pharmaceuticals share count unchanged in Q1 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #931 holding.
  • Salomon & Ludwin first reported a position in Ionis Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Salomon & Ludwin's Ionis Pharmaceuticals position peaked at $26.1K in Q4 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.